Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE